Moderna : Des avancées scientifiques pour avoir une longueur d’avance
>La science reste le nerf de la guerre - Moderna organisait hier son 4eme CMD tourné sur la Science. Résumé ici en quelques lignes les ambitions, opportunités mais aussi défis d’une plateforme technologique qui est qu’au début de son histoire n’est pas chose aisée. En 2021, Moderna ambitionne de réaliser plus de 19 Md$ de ventes grâce à son vaccin COVID-19 ce qui en fera un des acteurs les plus importants du marché du vaccin global. Ces ventes accompagnées d’une ...Moderna is creating a new generation of medicines based on messenger RNA to improve the lives of patients. The company uses its platform to identify and develop new mRNA medicines. When the company identifies a combination of platform technologies or programs across mRNA technologies, delivery technologies, and manufacturing processes that can enable shared product features across multiple potential mRNA medicines, it groups those programs as a modality. The company has created six modalities including prohylactic vaccines; cancer vaccines; intratumoral immuno-oncology; localized regenerative therapeuctics; systemic secreted therapeutics; and systemic intracellular therapeutics.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.